Formulary guidance and transparency from P&T to point of care

Perspectives on Real-World Data

Posted by Matt Breese on Nov 7, 2017

Find me on:


The pharmaceutical industry has seen an explosion in the availability of real-world data in recent years. In the past, pharma companies mainly relied on data from clinical trials. Today, real-world data provides new insights and opportunities to assess a broader population.

This information is increasingly influencing healthcare decision-makers. However, data scientists must have the skills to sort through unstructured health data, analyze it, understand the big picture, and portray the data visually. 

Why is real-world health data valuable? According to Ryan Copping, Contributor to the Harvard Business Review:

"Patient data collected in real time during doctor or hospital visits provides an opportunity to better understand diseases, treatment patterns, and clinical outcomes in an uncontrolled, real-world setting. It also allows companies to assess real-world challenges that cannot be observed in a clinical trial, such as drug compliance and the utilization of health care resources."

Real-world data can come from a variety of different sources. Here are a few of the current sources given by the FDA

  • Electronic health records (EHRs)
  • Claims and billing activities
  • Product and disease registries
  • Patient-related activities in out-patient or in-home use settings
  • Health-monitoring devices

While these electronic tools generate many opportunities, they also bring business challenges. As Ryan Copping states:

"For the industry, the biggest challenge by far has been talent: upgrading skill sets from those sufficient to analyze relatively small amounts of clinical trial data to those required to gain insights from the vast amount of real-world data, including unstructured data such as physicians’ notes, scans and images, and pathology reports."

In upcoming years, it will remain important for pharma companies to stay up-to-date on analytical tools. To make a significant impact, it is essential to implement consistent data management and data sharing processes company-wide. 

Subscribe to the MMIT blog for more pharma, provider, and payer perspectives on key topics that affect the healthcare network.

Subscribe for Weekly Perspectives

Topics: Industry Trends, Data & Analytics